Private Advisor Group’s Insmed INSM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$505K Sell
4,740
-9
-0.2% -$1.09K ﹤0.01% 1795
2026
Q1
$777K Buy
4,749
+82
+2% +$12.6K ﹤0.01% 1584
2025
Q4
$812K Sell
4,667
-64
-1% -$11.7K ﹤0.01% 1524
2025
Q3
$681K Sell
4,731
-79
-2% -$9.68K ﹤0.01% 1601
2025
Q2
$484K Buy
4,810
+267
+6% +$20.4K ﹤0.01% 1710
2025
Q1
$347K Sell
4,543
-1,000
-18% -$76.5K ﹤0.01% 1791
2024
Q4
$383K Sell
5,543
-116
-2% -$8.35K ﹤0.01% 1727
2024
Q3
$413K Sell
5,659
-2,918
-34% -$215K ﹤0.01% 1731
2024
Q2
$575K Buy
+8,577
New +$333K ﹤0.01% 1495

Other funds holding INSM

Private Advisor Group's INSM Position: Q2 2026 in Review

Private Advisor Group reduced its Insmed (INSM) stake by 0.19% in Q2 2026, selling an estimated $1.09K and leaving 4,740 shares worth $505K. The position accounts for ﹤0.01% of the portfolio, ranked #1795.

Private Advisor Group first reported a position in INSM in Q2 2024 and has held it in 9 quarters since. The position peaked at $812K in Q4 2025. 665 funds tracked by Wall St. Rank hold INSM as of Q2 2026.

  • Private Advisor Group held 4,740 shares of Insmed worth $505K as of Q2 2026.
  • Private Advisor Group sold 9 Insmed shares in Q2 2026, an estimated $1.09K.
  • Insmed made up ﹤0.01% of Private Advisor Group's portfolio in Q2 2026, its #1795 holding.
  • Private Advisor Group first reported a position in Insmed in Q2 2024 and has held it in 9 quarters since.
  • Private Advisor Group's Insmed position peaked at $812K in Q4 2025.
  • 665 funds tracked by Wall St. Rank held Insmed as of Q2 2026.

Based on Private Advisor Group's 13F filing for Q2 2026, filed 27 Jul 2026.